Saturday, July 11, 2026

Drug profile · INN

ethanolamine oleate

ethanolamine oleate (ETHAMOLIN) is a calcium chelating agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ethanolamine oleate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

ethanolamine oleate (ETHAMOLIN) is a calcium chelating agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN ethanolamine oleate
Brand ETHAMOLIN
Mechanism Calcium chelating agent
Target Calcium
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Calcium chelating agent

Primary target: Calcium

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. amlodipine benzoate Voltage-gated L-type calcium channel blocker
  2. amlodipine besylate Voltage-gated L-type calcium channel blocker
  3. chlorzoxazone Intermediate conductance calcium-activated potassium channel protein 4 opener
  4. cinacalcet hydrochloride Calcium sensing receptor positive allosteric modulator
  5. diltiazem hydrochloride Voltage-gated L-type calcium channel blocker
  6. ethosuximide Voltage-gated T-type calcium channel blocker

Frequently asked questions

What is ethanolamine oleate?

ethanolamine oleate (ETHAMOLIN) is a calcium chelating agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for ethanolamine oleate?

ETHAMOLIN is a marketed brand name for ethanolamine oleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ethanolamine oleate?

ethanolamine oleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.